Commentary: Biological tear substitutes: Overview, evidence, and future.
作者信息
Qazi Shakeel, Baig Kashif, Lalgudi Vaitheeswaran Ganesan
机构信息
Precision Cornea Centre, Ottawa, Ontario, Canada.
Precision Cornea Centre, Ottawa; Department of External Disease and Refractive Surgery, The Ottawa Hospital (TOH) - Cornea, University of Ottawa Eye Institute, Ontario, Canada.
出版信息
Indian J Ophthalmol. 2022 May;70(5):1554-1555. doi: 10.4103/ijo.IJO_162_22.
Abstract
摘要
相似文献
1
Commentary: Biological tear substitutes: Overview, evidence, and future.
Indian J Ophthalmol. 2022 May;70(5):1554-1555. doi: 10.4103/ijo.IJO_162_22.
2
Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease.
Int J Mol Sci. 2022 Feb 23;23(5):2434. doi: 10.3390/ijms23052434.
3
Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES7-DES12. doi: 10.1167/iovs.17-23475.
4
Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells.
Invest Ophthalmol Vis Sci. 2001 Apr;42(5):948-56.
5
Spectral-domain optical coherence tomography study on dynamic changes of human tears after instillation of artificial tears.
Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4533-40. doi: 10.1167/iovs.14-14666.
6
Comparative study of tear substitutes and their immediate effect on the precorneal tear film.
Isr J Med Sci. 1997 Mar;33(3):194-7.
7
Prevalence of Contralateral Hip Abductor Tears and Factors Associated With Symptomatic Progression.
Am J Sports Med. 2022 May;50(6):1603-1608. doi: 10.1177/03635465221083671.
8
Biomicroscopy of the tear film: aqueous and lipid tear substitutes in the normal and abnormal eye.
Vet Rec. 1988 Sep 24;123(13):329-35. doi: 10.1136/vr.123.13.329.
9
Efficacy and retention time of a new tear substitute.
Acta Ophthalmol (Copenh). 1993 Dec;71(6):836-8. doi: 10.1111/j.1755-3768.1993.tb08610.x.
10
The effect of tear substitutes on tear film break-up time.
Invest Ophthalmol. 1975 Mar;14(3):255-8.
引用本文的文献
1
Progress and Prospects in the Treatment of Lacrimal Gland Dysfunction Diseases: From Traditional Treatment Methods to Stem Cell and Organoid Therapies.
Stem Cells Int. 2025 Aug 8;2025:6334284. doi: 10.1155/sci/6334284. eCollection 2025.
本文引用的文献
1
Autologous platelet-rich plasma eye drop versus artificial tear eye drop for symptomatic dry eye disease: A prospective comparative interventional study.
Indian J Ophthalmol. 2022 May;70(5):1549-1553. doi: 10.4103/ijo.IJO_2595_21.
2
Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis.
Cornea. 2022 Sep 1;41(9):1137-1149. doi: 10.1097/ICO.0000000000002943. Epub 2021 Dec 20.
3
Blood derived eye drops for the treatment of cornea and ocular surface diseases.
Transfus Apher Sci. 2017 Aug;56(4):595-604. doi: 10.1016/j.transci.2017.07.023. Epub 2017 Aug 8.
4
Autologous serum eye drops for dry eye.
Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD009327. doi: 10.1002/14651858.CD009327.pub3.
5
Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects.
Cornea. 2009 Dec;28(10):1104-8. doi: 10.1097/ICO.0b013e3181a2a7f6.
6
Autologous serum eyedrops: literature review and implications for transfusion medicine specialists.
Transfusion. 2008 Jun;48(6):1245-55. doi: 10.1111/j.1537-2995.2008.01665.x. Epub 2008 Apr 10.
7
An optimised protocol for the production of autologous serum eyedrops.
Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):706-14. doi: 10.1007/s00417-004-1106-5. Epub 2005 Mar 9.
Zotero 插件